Yang Huang
Stock Analyst at J.P. Morgan
(4.79)
# 487
Out of 4,501 analysts
118
Total ratings
69.5%
Success rate
34.3%
Average return
Main Sectors:
Stocks Rated by Yang Huang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 9995 RemeGen Co., Ltd. | Maintained: Buy | $129.00 | $84.10 | +53.39% | 13 | Jun 9, 2026 | |
| HKG: 1801 Innovent Biologics, Inc. | Maintained: Buy | $111.00 → $113.00 | $89.70 | +25.98% | 18 | Apr 30, 2026 | |
| HKG: 2359 WuXi AppTec Co., Ltd. | Maintained: Buy | $138.00 → $150.00 | $155.10 | -3.29% | 11 | Mar 26, 2026 | |
| HKG: 6990 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Maintained: Buy | $499.00 → $545.00 | $516.50 | +5.52% | 2 | Nov 24, 2025 | |
| HKG: 1877 Shanghai Junshi Biosciences Co., Ltd. | Maintained: Sell | $18.00 → $20.00 | $19.37 | +3.25% | 9 | Oct 30, 2025 | |
| HKG: 3347 Hangzhou Tigermed Consulting Co., Ltd | Maintained: Sell | $37.00 → $38.00 | $36.66 | +3.66% | 8 | Oct 29, 2025 | |
| HKG: 3692 Hansoh Pharmaceutical Group Company Limited | Initiated Coverage: Buy | $43.00 | $31.94 | +34.63% | 1 | Sep 25, 2025 | |
| HKG: 1276 Jiangsu Hengrui Pharmaceuticals Co.,Ltd | Initiated Coverage: Hold | $78.00 | $59.25 | +31.65% | 1 | Sep 23, 2025 | |
| HKG: 9926 Akeso, Inc. | Maintained: Buy | $99.00 → $166.00 | $97.25 | +70.69% | 11 | Aug 27, 2025 | |
| HKG: 1548 Genscript Biotech Corporation | Maintained: Buy | $16.00 → $24.00 | $13.84 | +73.41% | 2 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36.00 → $37.00 | $37.96 | -2.53% | 10 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46.00 → $74.00 | $60.30 | +22.72% | 6 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52.00 → $93.00 | $36.36 | +155.78% | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $84.00 → $80.00 | $37.30 | n/a | 2 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $186.00 → $183.60 | $183.50 | n/a | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $3.40 | $1.55 | n/a | 1 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $217 → $64 | $20.49 | n/a | 3 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $4.80 → $3.00 | $1.92 | n/a | 3 | Jan 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $26.50 | $7.54 | n/a | 1 | Jan 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14.00 | $8.11 | n/a | 4 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18.00 | $11.90 | n/a | 2 | Aug 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $9.00 → $11.00 | $18.07 | n/a | 2 | Jun 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $230 → $169 | $298.70 | n/a | 4 | Mar 26, 2020 |
RemeGen Co., Ltd.
Jun 9, 2026
Maintained: Buy
Price Target: $129.00
Current: $84.10
Upside: +53.39%
Innovent Biologics, Inc.
Apr 30, 2026
Maintained: Buy
Price Target: $111.00 → $113.00
Current: $89.70
Upside: +25.98%
WuXi AppTec Co., Ltd.
Mar 26, 2026
Maintained: Buy
Price Target: $138.00 → $150.00
Current: $155.10
Upside: -3.29%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Nov 24, 2025
Maintained: Buy
Price Target: $499.00 → $545.00
Current: $516.50
Upside: +5.52%
Shanghai Junshi Biosciences Co., Ltd.
Oct 30, 2025
Maintained: Sell
Price Target: $18.00 → $20.00
Current: $19.37
Upside: +3.25%
Hangzhou Tigermed Consulting Co., Ltd
Oct 29, 2025
Maintained: Sell
Price Target: $37.00 → $38.00
Current: $36.66
Upside: +3.66%
Hansoh Pharmaceutical Group Company Limited
Sep 25, 2025
Initiated Coverage: Buy
Price Target: $43.00
Current: $31.94
Upside: +34.63%
Jiangsu Hengrui Pharmaceuticals Co.,Ltd
Sep 23, 2025
Initiated Coverage: Hold
Price Target: $78.00
Current: $59.25
Upside: +31.65%
Akeso, Inc.
Aug 27, 2025
Maintained: Buy
Price Target: $99.00 → $166.00
Current: $97.25
Upside: +70.69%
Genscript Biotech Corporation
Aug 21, 2025
Maintained: Buy
Price Target: $16.00 → $24.00
Current: $13.84
Upside: +73.41%
Aug 21, 2025
Maintained: Buy
Price Target: $36.00 → $37.00
Current: $37.96
Upside: -2.53%
Aug 14, 2025
Maintained: Buy
Price Target: $46.00 → $74.00
Current: $60.30
Upside: +22.72%
Aug 7, 2025
Maintained: Buy
Price Target: $52.00 → $93.00
Current: $36.36
Upside: +155.78%
May 16, 2023
Maintained: Buy
Price Target: $84.00 → $80.00
Current: $37.30
Upside: n/a
Mar 7, 2023
Maintained: Buy
Price Target: $186.00 → $183.60
Current: $183.50
Upside: n/a
Feb 22, 2023
Upgraded: Buy
Price Target: $3.40
Current: $1.55
Upside: n/a
Nov 14, 2022
Maintained: Buy
Price Target: $217 → $64
Current: $20.49
Upside: n/a
Jan 6, 2022
Downgraded: Sell
Price Target: $4.80 → $3.00
Current: $1.92
Upside: n/a
Jan 6, 2022
Downgraded: Sell
Price Target: $26.50
Current: $7.54
Upside: n/a
Aug 31, 2021
Maintained: Buy
Price Target: $14.00
Current: $8.11
Upside: n/a
Aug 27, 2021
Maintained: Hold
Price Target: $18.00
Current: $11.90
Upside: n/a
Jun 29, 2021
Downgraded: Hold
Price Target: $9.00 → $11.00
Current: $18.07
Upside: n/a
Mar 26, 2020
Maintained: Buy
Price Target: $230 → $169
Current: $298.70
Upside: n/a